The ethics of placebo in studies with fracture end points in osteoporosis.
Stein
C Michael
CM
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, USA.
Ray
Wayne A
WA
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D010919:Placebos / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics* / Q000379:methods
D050071:Bone Density Conservation Agents; D010919:Placebos